Laura A Shay1, Austin S Baldwin2, Andrea C Betts3,4, Emily G Marks3, Robin T Higashi3, Richard L Street5,6, Donna Persaud7, Jasmin A Tiro8,9. 1. Department of Health Promotion & Behavioral Sciences, UTHealth School of Public Health in San Antonio, San Antonio, Texas. 2. Department of Psychology, Southern Methodist University, Dallas, Texas. 3. Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, Texas. 4. Department of Health Promotion & Behavioral Sciences, UTHealth School of Public Health in Dallas, Dallas, Texas. 5. Department of Communication, Texas Agricultural and Mechanical University, College Station, Texas. 6. Department of Medicine, Baylor College of Medicine, Houston, Texas. 7. Parkland Health and Hospital System, Dallas, Texas; and. 8. Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, Texas; jasmin.tiro@utsouthwestern.edu. 9. Harold C. Simmons Comprehensive Cancer Center, Dallas, Texas.
Abstract
: media-1vid110.1542/5754332185001PEDS-VA_2017-2312Video Abstract OBJECTIVES: To prevent human papillomavirus (HPV)-related cancers, providers must effectively communicate with HPV vaccine-hesitant parents. Here, we developed a typology characterizing parent-provider communication around HPV vaccine hesitancy. METHODS: We audio-recorded 43 visits with unvaccinated adolescents at 6 pediatric clinics in Dallas, Texas in which parents were undecided about HPV vaccination. We qualitatively coded how parents verbally expressed hesitancy (assertive response, asking a question, or expressing concern) and whether providers responded with acquiescence (agree to defer vaccination) and/or persistence (continue discussion). We described the frequency of parent and provider communication codes and same-day vaccination. RESULTS: Among the 43 visits, 37 parents expressed hesitancy ≥1 times in many ways. Assertive responses were most common (27 visits), followed by questions (16 visits), and concerns (12 visits). When the first expression of hesitancy was a question or concern, 71% and 75% of adolescents, respectively, received same-day vaccinations, whereas 33% of adolescents who received an initial assertive response were vaccinated. Providers responded with only persistence in 18 visits, a mix of acquiescence and persistence in 13 visits, and only acquiescence in 6 visits. When providers only used persistence, 17 of 18 adolescents were vaccinated; when providers responded with only acquiescence, no adolescents received the vaccine. CONCLUSIONS: Our exploratory analysis reveals that providers engaging hesitant parents and addressing their concerns can lead to same-day HPV vaccination. Data reveal that even parents making assertive statements are amenable to influence by providers. Our findings reveal an important missed opportunity when providers simply acquiesce to parental hesitation.
: media-1vid110.1542/5754332185001PEDS-VA_2017-2312Video Abstract OBJECTIVES: To prevent human papillomavirus (HPV)-related cancers, providers must effectively communicate with HPV vaccine-hesitant parents. Here, we developed a typology characterizing parent-provider communication around HPV vaccine hesitancy. METHODS: We audio-recorded 43 visits with unvaccinated adolescents at 6 pediatric clinics in Dallas, Texas in which parents were undecided about HPV vaccination. We qualitatively coded how parents verbally expressed hesitancy (assertive response, asking a question, or expressing concern) and whether providers responded with acquiescence (agree to defer vaccination) and/or persistence (continue discussion). We described the frequency of parent and provider communication codes and same-day vaccination. RESULTS: Among the 43 visits, 37 parents expressed hesitancy ≥1 times in many ways. Assertive responses were most common (27 visits), followed by questions (16 visits), and concerns (12 visits). When the first expression of hesitancy was a question or concern, 71% and 75% of adolescents, respectively, received same-day vaccinations, whereas 33% of adolescents who received an initial assertive response were vaccinated. Providers responded with only persistence in 18 visits, a mix of acquiescence and persistence in 13 visits, and only acquiescence in 6 visits. When providers only used persistence, 17 of 18 adolescents were vaccinated; when providers responded with only acquiescence, no adolescents received the vaccine. CONCLUSIONS: Our exploratory analysis reveals that providers engaging hesitant parents and addressing their concerns can lead to same-day HPV vaccination. Data reveal that even parents making assertive statements are amenable to influence by providers. Our findings reveal an important missed opportunity when providers simply acquiesce to parental hesitation.
Authors: Douglas J Opel; Rita Mangione-Smith; Jeffrey D Robinson; John Heritage; Victoria DeVere; Halle S Salas; Chuan Zhou; James A Taylor Journal: Am J Public Health Date: 2015-03-19 Impact factor: 9.308
Authors: Sharon J M Kessels; Helen S Marshall; Maureen Watson; Annette J Braunack-Mayer; Rob Reuzel; Rebecca L Tooher Journal: Vaccine Date: 2012-04-03 Impact factor: 3.641
Authors: James R Roberts; David Thompson; Brianna Rogacki; Jessica J Hale; Robert M Jacobson; Douglas J Opel; Paul M Darden Journal: Vaccine Date: 2015-02-07 Impact factor: 3.641
Authors: Catherine Hough-Telford; David W Kimberlin; Inmaculada Aban; William P Hitchcock; Jon Almquist; Richard Kratz; Karen G O'Connor Journal: Pediatrics Date: 2016-09 Impact factor: 7.124
Authors: Rachel Herman; Louise-Anne McNutt; Mehek Mehta; Daniel A Salmon; Robert A Bednarczyk; Jana Shaw Journal: Hum Vaccin Immunother Date: 2019-03-14 Impact factor: 3.452
Authors: Peng-Jun Lu; David Yankey; Benjamin Fredua; Alissa C O'Halloran; Charnetta Williams; Lauri E Markowitz; Laurie D Elam-Evans Journal: J Pediatr Date: 2018-11-15 Impact factor: 4.406
Authors: Allison Kempe; Sean T O'Leary; Lauri E Markowitz; Lori A Crane; Laura P Hurley; Michaela Brtnikova; Brenda L Beaty; Elissa Meites; Shannon Stokley; Megan C Lindley Journal: Pediatrics Date: 2019-09-16 Impact factor: 7.124
Authors: Beth L Hoffman; Jason B Colditz; Ariel Shensa; Riley Wolynn; Sanya Bathla Taneja; Elizabeth M Felter; Todd Wolynn; Jaime E Sidani Journal: Vaccine Date: 2021-04-13 Impact factor: 4.169
Authors: Brigid K Grabert; Jennifer Heisler-MacKinnon; Amy Liu; Marjorie A Margolis; Elizabeth D Cox; Melissa B Gilkey Journal: Hum Vaccin Immunother Date: 2021-06-21 Impact factor: 4.526